India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
While the forensic department is looking for the body of the deceased... How are the dead bodies identified in the plane crash? Forensic Department of Terti Teaching Hospital in Maharajganj. On other days, the students studying in medical education were going back and forth. The atmosphere here was different on Wednesday. The bodies of the 18 deceased who died in the Sourya Airlines plane crash were taken to the forensic department of the hospital for post-mortem. Relatives gathered outside in the courtyard, all of them full of tears. Some are lying on the ground. Some are moaning and beating their chests. Relatives were trying to support each other. He was interested to see if there would be any information. The police micked from inside, only two relatives of the deceased should come inside. Relatives gathered outside hurriedly tried to get inside. The police guarding the gate asked only the relatives of the deceased to go inside as there was a large crowd inside. Relatives expr...